sb 216763 has been researched along with Depression, Endogenous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, L; Hui, J; Jiang, D; Mao, X; Pu, M; Shi, G; Wu, J; Xi, G; Zhang, J; Zhou, X; Zou, J | 1 |
| Dang, YH; Gao, CG; Hashimoto, K; Jia, M; Ma, R; Ma, XC; Wang, F; Wu, J | 1 |
2 other study(ies) available for sb 216763 and Depression, Endogenous
| Article | Year |
|---|---|
Modulation of GSK-3β/β-Catenin Signaling Contributes to Learning and Memory Impairment in a Rat Model of Depression.
Topics: Animals; beta Catenin; Cognitive Dysfunction; Corticosterone; Depressive Disorder; Disease Models, Animal; Gene Transfer Techniques; Glycogen Synthase Kinase 3 beta; Hippocampus; Indoles; Intercellular Signaling Peptides and Proteins; Learning Disabilities; Male; Maleimides; Maze Learning; Memory Disorders; Nootropic Agents; Rats, Sprague-Dawley; Signal Transduction; Stress, Psychological; Uncertainty | 2018 |
Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Hindlimb Suspension; Humans; Indoles; Ketamine; Male; Maleimides; Mice; Motor Activity; Stress, Physiological; Sucrose | 2013 |